Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |